The ABSCF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ABSCF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ABSCF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View ABSCF Detailed Price Forecast - CNN Money | View ABSCF Detailed Summary - Google Finance | ||
View ABSCF Detailed Summary - Yahoo! Finance | View ABSCF Stock Research & Analysis - Zacks.com |
View ABSCF Trends & Analysis - Trade-Ideas | View ABSCF Major Holders - Barrons | ||
View ABSCF Call Transcripts - NASDAQ | View ABSCF Breaking News & Analysis - Seeking Alpha | ||
View ABSCF Annual Report - CompanySpotlight.com | View ABSCF OTC Short Report - OTCShortReport.com | ||
View ABSCF Fundamentals - TradeKing | View ABSCF SEC Filings - Bar Chart | ||
View Historical Prices for ABSCF - The WSJ | View Performance/Total Return for ABSCF - Morningstar | ||
View the Analyst Estimates for ABSCF - MarketWatch | View the Earnings History for ABSCF - CNBC | ||
View the ABSCF Earnings - StockMarketWatch | View ABSCF Buy or Sell Recommendations - MacroAxis | ||
View the ABSCF Bullish Patterns - American Bulls | View ABSCF Short Pain Metrics - ShortPainBot.com |
View ABSCF Stock Mentions - StockTwits | View ABSCF Stock Mentions - PennyStockTweets | ||
View ABSCF Stock Mentions - Twitter | View ABSCF Investment Forum News - Investor Hub | ||
View ABSCF Stock Mentions - Yahoo! Message Board | View ABSCF Stock Mentions - Seeking Alpha |
View Insider Transactions for ABSCF - SECform4.com | View Insider Transactions for ABSCF - Insider Cow | ||
View ABSCF Major Holdings Summary - CNBC | View Insider Disclosure for ABSCF - OTC Markets | ||
View Insider Transactions for ABSCF - Yahoo! Finance | View Institutional Holdings for ABSCF - NASDAQ |
View ABSCF Stock Insight & Charts - FinViz.com | View ABSCF Investment Charts - StockCharts.com | ||
View ABSCF Stock Overview & Charts - BarChart | View ABSCF User Generated Charts - Trading View |
AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS
Posted on Wednesday April 03, 2024
PRESS RELEASE AB SCIENCE ANNOUNCES THAT HEALTH CANADA HAS GRANTED ELIGIBILITY FOR RECONSIDERATION REQUEST FOR MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS Paris, 3 April, 2024, 6pm CET AB Science SA (Euronext - FR0010557264 - AB) today announces that Health Canada has granted eligibility for reconsideration request for masitinib in amyotrophic lateral sclerosis (ALS). The reconsideration process will re-examine, with new assessors, the decision based on information that was included in the origina
AB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease
Posted on Wednesday March 13, 2024
PRESS RELEASE NEW RESEARCH SHOWS THAT MASITINIB LIMITS NEURONAL DAMAGE IN A MODEL OF NEUROIMMUNE-DRIVEN NEURODEGENERATIVE DISEASE THIS IS THE FIRST DEMONSTRATION THAT MASITINIB CAN LOWER SERUM NEUROFILAMENT LIGHT CHAIN, AN IMPORTANT BIOMARKER FOR NEURODEGENERATIVE DISORDERS Paris, March 13, 2024, 12.45pm CET AB Science SA (Euronext - FR0010557264 - AB) today announced the publication of new preclinical results for masitinib in neurodegenerative diseases (NDD). Findings have been published on the
AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development
Posted on Thursday March 07, 2024
PRESS RELEASE SUMMARY OF THE WEBCAST HELD ON MARCH 4, 2024 PROVIDING AN UPDATE ON AB SCIENCE DEVELOPMENT Paris, March 7, 2024, 3pm CET AB Science SA (Euronext - FR0010557264 - AB) is providing a summary of the live webcast held on March 4, 2024, giving an update on AB Science development. The webcast presentation is available on the company’s website, in the section « Press Releases »: https://www.ab-science.com/news-and-media/press-releases/ The presentation covered four topics: Status of condi
AB Science announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated coverage of the Company
Posted on Wednesday March 06, 2024
PRESS RELEASE TWO NEW FINANCIAL ANALYSIS FIRMS INITIATE COVERAGE OF AB SCIENCE Paris, March 6, 2024, 8.15pm CET AB Science SA (Euronext - FR0010557264 - AB) announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated the coverage of the Company. DNA Finance estimates that AB Science stands out as a compelling investment opportunity in the biotech sector. In Extenso has initiated a strong buy opinion on the share. These new coverages aim to strengthen the AB Sc